Bond.az White LogoBond.az Black Logo

ProLogium SPAC Merger Valued at $3.8B

ProLogium, a solid-state battery manufacturer, goes public via SPAC merger at $3.8 billion valuation on Nasdaq.

Charlotte Hernandez
ByCharlotte Hernandez- Senior Editor
|
0

Solid-state battery maker ProLogium is going public via a SPAC merger with Translational Development Acquisition Corp.

The combined company, ProLogium Technology, will trade on Nasdaq under the ticker PRLG.

The transaction values ProLogium at approximately $3.8 billion on a pre-money, net cash-free basis.

Founded in 2006, ProLogium produces lithium ceramic batteries and holds over 1,100 global patents.

The company has shipped over 2.4 million battery cells since 2013.

Its fourth-generation battery technology features a triple safety mechanism.

Proceeds will fund production scaling and construction of a gigafactory in Dunkirk, France.

The French government has approved up to €1.4 billion in subsidies.

The merger is expected to close in the second half of 2026.

More News
Today / 11:34
|
415

Newcleo to Go Public via SPAC Merger at $2.4B Valuation

Newcleo merges with SPAC NewHold at $2.4B valuation, lists on Nasdaq as NWCL. PIPE of $220M included. Transaction expected to close in 2026.

0
Today / 11:33
|
285

Erdene publishes 2026 shareholder letter, schedules meeting

Erdene Resource Development Corp. published its 2026 shareholder letter and scheduled its annual meeting. Details on the Bayan Khundii gold mine operations.

0
Today / 09:02
|
855

FP-001 42 mg Clinical Trial Completed

Foresee Pharmaceuticals completes Phase 3 trial for FP-001 42 mg for precocious puberty. FDA submission planned for 2026. CAMCEVI 21mg approved in Europe.

0
Today / 07:05
|
446

Eden Research director resigns

Eden Research non-executive director Derek McAllan resigns due to ill health. Rob Cridland appointed interim Audit Committee chair.

0
Today / 06:31
|
362

HgCapital Trust invests £11m in Rightsline software

HgCapital Trust invests £11 million in Rightsline, a rights and royalties management software provider, as part of a $500M growth round.

0
Today / 01:32
|
429

Junshi Biosciences completes phase III lung cancer study

Junshi Biosciences completes phase III lung cancer study. Toripalimab combination shows promising results in resectable stage II-III NSCLC.

0
Yesterday / 21:31
|
985

Cheniere $2B Senior Notes Pricing

Cheniere Energy Partners prices $2 billion senior notes offering in two tranches with maturities in 2036 and 2056.

0
Yesterday / 19:01
|
244

Healthpeak Properties Stock Hits 52-Week High

Healthpeak Properties stock hits 52-week high of $19.94. Annual return 26%, dividend yield 6.2%. Q1 EPS beats estimates by 369%.

0
Yesterday / 19:00
|
392

Arbor Realty Trust Stock Hits 52-Week Low at $5.48

Arbor Realty Trust stock hits 52-week low at $5.48. RSI oversold, dividend yield 12.21%. Bond.az analysis suggests undervaluation.

0
Yesterday / 18:02
|
692

Ormat Technologies Stock Hits Record High

Ormat Technologies stock hits all-time high at $138.53. 90.59% annual surge, strong Q1 earnings, and renewable energy leadership insights.

0
Yesterday / 18:01
|
793

Hutchmed stock hits 52-week low at 11.7 USD

Hutchmed stock hits 52-week low at $11.70. P/E 4.64, fair value $14.06. Strong oncology earnings from HUTCHMED.

0
Yesterday / 17:32
|
580

TestEquity Names 5 Senior Executives

TestEquity appoints five senior executives and promotes its Mexico head to drive growth strategy. Find out more.

0
...
ProLogium SPAC Merger Valued at $3.8B | Bond.az